末梢血管ステントの世界市場

Future Market Insightsが発行した調査報告書(FUMI809257)
◆英語タイトル:Peripheral Vascular Stents Market: Increasing Demand for Drug Eluting Stents to be Observed During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028
◆商品コード:FUMI809257
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2018年7月17日
◆ページ数:263
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療・医薬品・医療機器
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Future Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートでは、末梢血管ステントの世界市場について調査・分析し、以下の構成でお届けいたします。
・末梢血管ステントの世界市場の世界市場概観
・末梢血管ステントの世界市場の世界市場規模
・末梢血管ステントの世界市場の世界市場予測
・末梢血管ステントの世界市場の世界市場:地域別市場分析
・末梢血管ステントの世界市場のアメリカ市場規模
・末梢血管ステントの世界市場のヨーロッパ市場規模
・末梢血管ステントの世界市場のアジア市場規模
・末梢血管ステントの世界市場の世界市場:セグメント別市場分析
・末梢血管ステントの世界市場の世界市場:競争状況
・末梢血管ステントの世界市場の世界市場:市場動向
・末梢血管ステントの世界市場の世界市場:関連企業分析
【レポートの概要】

Report Description

This Future Market Insights (FMI) report examines the global peripheral vascular stents market for the period 2013–2028. The primary objective of the report is to offer insights into market opportunity for peripheral vascular stents and developments in the peripheral vascular stents market.

The global peripheral vascular stents market has witnessed spontaneous changes in peripheral surgical landscape after the launch of new products, such as drug eluting and drug coated, and initiation of public–private alliances to widen the use of stents in endovascular interventions. According to the Centre for Disease Control and Prevention (CDC), approximately 8.5 million people in the U.S. suffer from PAD, including 12–20% of individuals older than age 60. This increasing prevalence of peripheral artery diseases and growing healthcare expenditure in lower-middle income countries are factors projected to boost the growth of the global peripheral vascular stents market over the forecast period.

The market for peripheral vascular stents is primarily driven by increasing prevalence of peripheral artery disease (PAD), rise in ageing population, increase in number of outpatient surgeries, and growing preference of peripheral surgery. However, stringent regulations and recall of products are the factors limiting growth of the global peripheral vascular stents market.

The Global Peripheral Vascular Stents Market has been segmented based on:

Product Type
Artery Type
End User
Regions
The report analyses the global peripheral vascular stents market in terms of value (US$ Mn). The report begins with the market definition and explaining different types and causes of peripheral artery disease and use of peripheral stents, and highlighting self-expanding peripheral stents. This section also explains the prevalence of peripheral artery disease across key regions. The market view point section includes FMI’s analysis on key trends, drivers, opportunities, trends and macro factors influencing the global peripheral vascular stents market. Opportunity analysis provided in the section allows clients to better equip with crystal clear decision-making insights.

The report analyses the market based on regions and presents the forecast in terms of value (US$ Mn) for the next 10 years. The regions covered in the report include:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan (APEJ)
Japan
The Middle East and Africa (MEA)
Each of these sections analyse the regional market by product type, artery type, end user and country. The regional introductory section provides key insights on market dynamics for each region. The section is mainly designed to provide current scenario of the peripheral vascular stents market and forecast for 2018–2028. The representative market participants section gives list of companies operating in each region, competitive landscape and intensity map of their presence in each region.

To arrive at the market size, we have used our in-house epidemiology data-based model to estimate the peripheral vascular stents market size. We have adopted bottom-up approach to forecast the peripheral vascular stents market. Weighted average selling price is considered to estimate the market size of various product types mentioned in the scope of the report. The country price is captured with the local currency. The local currency figures are then converted to USD to offer forecasts in a consistent currency standard. Furthermore, FMI has also considered the latest annual exchange rate to reflect the impact of the most recent economic conditions of country. Prices considered in the models are standardized based on the average of various product type.

The forecast presented in the report provides total revenue of the currently approved peripheral vascular stents over 2018–2028. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

In the next section of the report, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view and to access the key differentiators among the competitor firms. The market structure analysis provides tier-wise breakdown of the total market revenue. The section also provides company share analysis and brand share analysis for the key market players. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to the market segments. Detailed profiles of players operating in the global peripheral vascular stents market are also provided in the report which highlights company description, overview, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.

The next section of report analyses the market based on product types and presents the forecast in terms of value for the next 10 years. The product types covered in the report include:

Self-Expanding Stents
Balloon Expanding Stents
Covered Stents
Drug Eluting Stents
The next section of the report analyses the market based on artery types and provides forecast in terms of value for the next 10 years. The artery types covered in the report include:

Carotid Artery
Fem-Pop Artery
Iliac Artery
Infrapop Artery
The next section of report analyses the market based on end user for peripheral vascular stents products and provides forecast in terms of value for the next 10 years. The end users covered in the report include:

Hospitals
Ambulatory Surgical Centres/Outpatients
Another key feature of this report is the analysis of the key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the products. To understand the key growth segments, Future Market Insights provides the ‘Attractiveness Index’ analysis, which helps to identify the real market opportunities.

【レポートの目次】

Table Of Content
1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Global Peripheral Vascular Stents Market Opportunity Analysis

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4. Market Background

4.1. Key Manufacturer List

4.2. Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Trends

5. Key Inclusions

5.1. Regulatory Scenario

5.2. Reimbursement Scenario

5.3. Pricing Analysis

6. North America Peripheral Vascular Stents Market Analysis 2013-2017 and Forecast 2018–2028

6.1. Introduction

6.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

6.2.1. U.S.

6.2.2. Canada

6.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

6.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

6.4.1. Self-Expanding Stents

6.4.2. Balloon Expanding Stents

6.4.3. Covered Stents

6.4.4. Drug Eluting Stents

6.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

6.6. Historical Market Size (US$ Mn) Analysis By Artery Type, 2013-2017

6.6.1. Carotid Artery

6.6.2. Fem-Pop Artery

6.6.3. Iliac Artery

6.6.4. Infrapop Artery

6.7. Market Size (US$ Mn) Forecast By Artery Type, 2018–2028

6.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017

6.8.1. Hospitals

6.8.2. Ambulatory Surgical Centers/Outpatients

6.9. Market Size (US$ Mn) Forecast By End User, 2018–2028

6.10. Market Attractiveness Analysis

6.10.1. By Country

6.10.2. By Product Type

6.10.3. By Artery Type

6.10.4. By End User

6.11. Key Market Participants – Intensity Mapping

6.12. Drivers and Restraints: Impact Analysis

7. Latin America Peripheral Vascular Stents Market Analysis 2013-2017 and Forecast 2018–2028

7.1. Introduction

7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

7.2.1. Brazil

7.2.2. Mexico

7.2.3. Argentina

7.2.4. Rest of Latin America

7.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

7.4.1. Self-Expanding Stents

7.4.2. Balloon Expanding Stents

7.4.3. Covered Stents

7.4.4. Drug Eluting Stents

7.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

7.6. Historical Market Size (US$ Mn) Analysis By Artery Type, 2013-2017

7.6.1. Carotid Artery

7.6.2. Fem-Pop Artery

7.6.3. Iliac Artery

7.6.4. Infrapop Artery

7.7. Market Size (US$ Mn) Forecast By Artery Type, 2018–2028

7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017

7.8.1. Hospitals

7.8.2. Ambulatory Surgical Centers/Outpatients

7.9. Market Size (US$ Mn) Forecast By End User, 2018–2028

7.10. Market Attractiveness Analysis

7.10.1. By Country

7.10.2. By Product Type

7.10.3. By Artery Type

7.10.4. By End User

7.11. Key Market Participants – Intensity Mapping

7.12. Drivers and Restraints: Impact Analysis

8. Western Europe Peripheral Vascular Stents Market Analysis 2013-2017 and Forecast 2018–2028

8.1. Introduction

8.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

8.2.1. Germany

8.2.2. U.K

8.2.3. France

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Western Europe

8.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

8.4.1. Self-Expanding Stents

8.4.2. Balloon Expanding Stents

8.4.3. Covered Stents

8.4.4. Drug Eluting Stents

8.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

8.6. Historical Market Size (US$ Mn) Analysis By Artery Type, 2013-2017

8.6.1. Carotid Artery

8.6.2. Fem-Pop Artery

8.6.3. Iliac Artery

8.6.4. Infrapop Artery

8.7. Market Size (US$ Mn) Forecast By Artery Type, 2018–2028

8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017

8.8.1. Hospitals

8.8.2. Ambulatory Surgical Centers/Outpatients

8.9. Market Size (US$ Mn) Forecast By End User, 2018–2028

8.10. Market Attractiveness Analysis

8.10.1. By Country

8.10.2. By Product Type

8.10.3. By Artery Type

8.10.4. By End User

8.11. Key Market Participants – Intensity Mapping

8.12. Drivers and Restraints: Impact Analysis

9. Eastern Europe Peripheral Vascular Stents Market Analysis 2013-2017 and Forecast 2018–2028

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

9.2.1. Russia

9.2.2. Poland

9.2.3. Rest of Eastern Europe

9.3. Market Size (US$ Mn) Forecast By Country, 2018–2028

9.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

9.4.1. Self-Expanding Stents

9.4.2. Balloon Expanding Stents

9.4.3. Covered Stents

9.4.4. Drug Eluting Stents

9.5. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

9.6. Historical Market Size (US$ Mn) Analysis By Artery Type, 2013-2017

9.6.1. Carotid Artery

9.6.2. Fem-Pop Artery

9.6.3. Iliac Artery

9.6.4. Infrapop Artery

9.7. Market Size (US$ Mn) Forecast By Artery Type, 2018–2028

9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017

9.8.1. Hospitals

9.8.2. Ambulatory Surgical Centers/Outpatients

9.9. Market Size (US$ Mn) Forecast By End User, 2018–2028

9.10. Market Attractiveness Analysis

9.10.1. By Country

9.10.2. By Product Type

9.10.3. By Artery Type

9.10.4. By End User

9.11. Key Market Participants – Intensity Mapping

9.12. Drivers and Restraints: Impact Analysis

10. Asia-Pacific Excluding Japan Peripheral Vascular Stents Market Analysis 2013-2017 and Forecast 2018–2028

10.1.Introduction

10.2.Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

10.2.1. India

10.2.2. Australia and New Zealand

10.2.3. China

10.2.4. Rest of APECJ

10.3.Market Size (US$ Mn) Forecast By Country, 2018–2028

10.4.Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

10.4.1. Self-Expanding Stents

10.4.2. Balloon Expanding Stents

10.4.3. Covered Stents

10.4.4. Drug Eluting Stents

10.5.Market Size (US$ Mn) Forecast By Product Type, 2018–2028

10.6.Historical Market Size (US$ Mn) Analysis By Artery Type, 2013-2017

10.6.1. Carotid Artery

10.6.2. Fem-Pop Artery

10.6.3. Iliac Artery

10.6.4. Infrapop Artery

10.7.Market Size (US$ Mn) Forecast By Artery Type, 2018–2028

10.8.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017

10.8.1. Hospitals

10.8.2. Ambulatory Surgical Centers/Outpatients

10.9.Market Size (US$ Mn) Forecast By End User, 2018–2028

10.10. Market Attractiveness Analysis

10.10.1. By Country

10.10.2. By Product Type

10.10.3. By Artery Type

10.10.4. By End User

10.11. Key Market Participants – Intensity Mapping

10.12. Drivers and Restraints: Impact Analysis

11. Japan Peripheral Vascular Stents Market Analysis 2013-2017 and Forecast 2018–2028

11.1.Introduction

11.2.Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

11.2.1. Self-Expanding Stents

11.2.2. Balloon Expanding Stents

11.2.3. Covered Stents

11.2.4. Drug Eluting Stents

11.3.Market Size (US$ Mn) Forecast By Product Type, 2018–2028

11.4.Historical Market Size (US$ Mn) Analysis By Artery Type, 2013-2017

11.4.1. Carotid Artery

11.4.2. Fem-Pop Artery

11.4.3. Iliac Artery

11.4.4. Infrapop Artery

11.5.Market Size (US$ Mn) Forecast By Artery Type, 2018–2028

11.6.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017

11.6.1. Hospitals

11.6.2. Ambulatory Surgical Centers/Outpatients

11.7.Market Size (US$ Mn) Forecast By End User, 2018–2028

11.8. Market Attractiveness Analysis

11.8.1. By Product Type

11.8.2. By Artery Type

11.8.3. By End User

11.9. Key Market Participants – Intensity Mapping

11.10. Drivers and Restraints: Impact Analysis

12. Middle East and Africa Peripheral Vascular Stents Market Analysis 2013-2017 and Forecast 2018–2028

12.1.Introduction

12.2.Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

12.2.1. GCC Countries

12.2.2. South Africa

12.2.3. Rest of MEA

12.3.Market Size (US$ Mn) Forecast By Country, 2018–2028

12.4.Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

12.4.1. Self-Expanding Stents

12.4.2. Balloon Expanding Stents

12.4.3. Covered Stents

12.4.4. Drug Eluting Stents

12.5.Market Size (US$ Mn) Forecast By Product Type, 2018–2028

12.6.Historical Market Size (US$ Mn) Analysis By Artery Type, 2013-2017

12.6.1. Carotid Artery

12.6.2. Fem-Pop Artery

12.6.3. Iliac Artery

12.6.4. Infrapop Artery

12.7.Market Size (US$ Mn) Forecast By Artery Type, 2018–2028

12.8.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017

12.8.1. Hospitals

12.8.2. Ambulatory Surgical Centers/Outpatients

12.9.Market Size (US$ Mn) Forecast By End User, 2018–2028

12.10. Market Attractiveness Analysis

12.10.1. By Country

12.10.2. By Product Type

12.10.3. By Artery Type

12.10.4. By End User

12.11. Key Market Participants – Intensity Mapping

12.12. Drivers and Restraints: Impact Analysis

13. Forecast Factors: Relevance and Impact

14. Forecast Assumptions

15. Market Structure Analysis

15.1.Market Structure by Tier

15.2.Market Share Analysis (2017) for Top Players

16. Competition Analysis

16.1.Competition Dashboard

16.2.Competitors Deep Dive

16.2.1. MicroPort Scientific Corporation

16.2.1.1. Overview

16.2.1.2. Product Portfolio

16.2.1.3. Production Footprint

16.2.1.4. Sales Footprint

16.2.1.5. Channel Footprint

16.2.1.6. Strategy

16.2.1.6.1.1. Marketing Strategy

16.2.1.6.1.2. Product Strategy

16.2.1.6.1.3. Channel Strategy

16.2.2. Medtronic Plc.

16.2.2.1. Product Portfolio

16.2.2.2. Production Footprint

16.2.2.3. Sales Footprint

16.2.2.4. Channel Footprint

16.2.2.5. Strategy

16.2.2.5.1.1. Marketing Strategy

16.2.2.5.1.2. Product Strategy

16.2.2.5.1.3. Channel Strategy

16.2.3. Becton, Dickinson and Company

16.2.3.1. Overview

16.2.3.2. Product Portfolio

16.2.3.3. Production Footprint

16.2.3.4. Sales Footprint

16.2.3.5. Channel Footprint

16.2.3.6. Strategy

16.2.3.6.1.1. Marketing Strategy

16.2.3.6.1.2. Product Strategy

16.2.3.6.1.3. Channel Strategy

16.2.4. Boston Scientific Corporation

16.2.4.1. Overview

16.2.4.2. Product Portfolio

16.2.4.3. Production Footprint

16.2.4.4. Sales Footprint

16.2.4.5. Channel Footprint

16.2.4.6. Strategy

16.2.4.6.1.1. Marketing Strategy

16.2.4.6.1.2. Product Strategy

16.2.4.6.1.3. Channel Strategy

16.2.5. Cardinal Health, Inc.

16.2.5.1. Overview

16.2.5.2. Product Portfolio

16.2.5.3. Production Footprint

16.2.5.4. Sales Footprint

16.2.5.5. Channel Footprint

16.2.5.6. Strategy

16.2.5.6.1.1. Marketing Strategy

16.2.5.6.1.2. Product Strategy

16.2.5.6.1.3. Channel Strategy

16.2.6. B. Braun Melsungen AG

16.2.6.1. Overview

16.2.6.2. Product Portfolio

16.2.6.3. Production Footprint

16.2.6.4. Sales Footprint

16.2.6.5. Channel Footprint

16.2.6.6. Strategy

16.2.6.6.1.1. Marketing Strategy

16.2.6.6.1.2. Product Strategy

16.2.6.6.1.3. Channel Strategy

16.2.7. Abbott Laboratories

16.2.7.1. Overview

16.2.7.2. Product Portfolio

16.2.7.3. Production Footprint

16.2.7.4. Sales Footprint

16.2.7.5. Channel Footprint

16.2.7.6. Strategy

16.2.7.6.1.1. Marketing Strategy

16.2.7.6.1.2. Product Strategy

16.2.7.6.1.3. Channel Strategy

16.2.8. BIOTRONIK SE & Co. KG

16.2.8.1. Overview

16.2.8.2. Product Portfolio

16.2.8.3. Production Footprint

16.2.8.4. Sales Footprint

16.2.8.5. Channel Footprint

16.2.8.6. Strategy

16.2.8.6.1.1. Marketing Strategy

16.2.8.6.1.2. Product Strategy

16.2.8.6.1.3. Channel Strategy

16.2.9. Cook Medical Inc.

16.2.9.1. Overview

16.2.9.2. Product Portfolio

16.2.9.3. Production Footprint

16.2.9.4. Sales Footprint

16.2.9.5. Channel Footprint

16.2.9.6. Strategy

16.2.9.6.1.1. Marketing Strategy

16.2.9.6.1.2. Product Strategy

16.2.9.6.1.3. Channel Strategy

16.2.10. W. L. Gore & Associates

16.2.10.1. Overview

16.2.10.2. Product Portfolio

16.2.10.3. Production Footprint

16.2.10.4. Sales Footprint

16.2.10.5. Channel Footprint

16.2.10.6. Strategy

16.2.10.6.1.1. Marketing Strategy

16.2.10.6.1.2. Product Strategy

16.2.10.6.1.3. Channel Strategy

16.2.10.6.1.4.

17. Global Peripheral Vascular Stents Market Analysis 2013-2017 and Forecast 2018–2028 By Region

17.1.Introduction / Key Findings

17.2.Historical Market Size (US$ Mn) Analysis By Region

17.2.1. North America

17.2.2. Western Europe

17.2.3. Eastern Europe

17.2.4. Latin America

17.2.5. Asia Pacific Excluding Japan

17.2.6. Japan

17.2.7. Middle East and Africa

17.3.Market Size (US$ Mn) Forecast By Region

17.3.1. North America

17.3.2. Western Europe

17.3.3. Eastern Europe

17.3.4. Latin America

17.3.5. Asia Pacific Excluding Japan

17.3.6. Japan

17.3.7. Middle East and Africa

17.4.Market Attractiveness Analysis By Region

18. Global Peripheral Vascular Stents Market Analysis 2013-2017 and Forecast 2018–2028, By Product Type

18.1.Introduction/Key Finding

18.2.Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

18.2.1. Self-Expanding Stents

18.2.2. Balloon Expanding Stents

18.2.3. Covered Stents

18.2.4. Drug Eluting Stents

18.3.Market Size (US$ Mn) Forecast By Product Type, 2018–2028

18.4.Market Attractiveness Analysis By Product Type

19. Global Peripheral Vascular Stents Market Analysis 2013-2017 and Forecast 2018–2028, By Artery Type

19.1.Introduction/Key Finding

19.2.Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

19.2.1. Carotid Artery

19.2.2. Fem-Pop Artery

19.2.3. Iliac Artery

19.2.4. Infrapop Artery

19.3.Market Size (US$ Mn) Forecast By Product Type, 2018–2028

19.4.Market Attractiveness Analysis By Product Type

20. Global Peripheral Vascular Stents Market Analysis 2013-2017 and Forecast 2018–2028, By End User

20.1.Introduction/Key Finding

20.2.Historical Market Size (US$ Mn) Analysis By End User, 2013-2017

20.2.1. Hospitals

20.2.2. Ambulatory Surgical Centers/Outpatients

20.3.Market Size (US$ Mn) Forecast By End User, 2018–2028

20.4.Market Attractiveness Analysis By End User

21. Global Peripheral Vascular Stents Market Analysis 2013-2017 and Forecast 2018–2028

21.1.Market Value Share Analysis By All Segment

21.2.Y-o-Y Growth Analysis By All Segment

21.3.Absolute $ Opportunity

22. Assumptions and Acronyms Used

23. Research Methodology



【レポートのキーワード】

末梢血管ステント

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 末梢血管ステントの世界市場(Peripheral Vascular Stents Market: Increasing Demand for Drug Eluting Stents to be Observed During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆